Skip to content
Lower risk Medical device recall · FDA · Published March 8, 2022

Abbott ARCHITECT STAT Myoglobin Calibrators Recall: Calibration Errors Risk

Abbott recalls ARCHITECT STAT Myoglobin Calibrators (RES 2K4:01) due to potential calibration errors. Controls may exceed specified ranges if used with this lot, affecting test accuracy.

🇺🇸 FDA recall #Z-0891-2022Medical deviceAbbott ›
Take action

Contact the company

Recalling firmAbbott Laboratories100 Abbott Park Rd Bldg Ap8b · Abbott Park, IL 60064-3502
✎ GovInfoNow plain-language explainer

Abbott is recalling specific ARCHITECT STAT Myoglobin Calibrators (RES 2K43-01) because they may cause calibration errors. This could lead to inaccurate test results if used in the ARCHITECT iSystem. Read more at govinfonow.com/recall/60975-abbott-architect-stat-myoglobin-calibrators-recall-calibration-errors-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/60975-abbott-architect-stat-myoglobin-calibrators-recall-calibration-errors-risk · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0891-2022

Cite this page

“Abbott ARCHITECT STAT Myoglobin Calibrators Recall: Calibration Errors Risk.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/60975-abbott-architect-stat-myoglobin-calibrators-recall-calibration-errors-risk. Based on FDA recall #Z-0891-2022 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0891-2022%22&limit=1).

The FDA announced on March 8, 2022, that Abbott Laboratories is recalling ARCHITECT STAT Myoglobin Calibrators because the lot failed stability testing. This defect may cause control values to exceed specified ranges during use.

How to tell if you have it

  • ARCHITECT STAT Myoglobin Calibrators, RES 2K43-01
  • UPC 00380740003272

The hazard

The calibrator lot did not meet acceptance criteria during ongoing stability testing. When a calibration is performed with this lot, controls may exceed the specified range in the Instructions for Use (IFU).

Context

GovInfoNow's records show Abbott Laboratories has 33 other recalls on record since May 14, 2012. Recent brand recalls include a November 13, 2025 correction for the Alinity ci-series System Control Module and a September 18, 2025 software issue for the Abbott Alinity hq Analyzer. Other recent recalls of similar products include Beckman Coulter Access Total T4 Calibrator Recall (March 16, 2026).

How to tell if you have this one

Check for the model RES 2K43-01 on the calibrator. The recall applies to products sold with the UDI (Unique Device Identification) code (01)00380740003272(17)220531(10)166000.

  • Brand
    Abbott
  • Product
    ARCHITECT STAT Myoglobin Calibrators, RES 2K43-01 The ARCHITECT STAT Myoglobin Calibrators are for the calibration of
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Calibration Results

    Review test results to ensure they fall within the specified range as per the Instructions for Use.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Worldwide Distribution: US (nationwide) and OUS (foreign) including countries of: AUSTRIA, BELGIUM, BOSNIA AND HERZEGOVI, CROATIA, CYPRUS, CZECH REPUBLIC, DENMARK, FRANCE, GERMANY, GREECE, IRAQ, ITALY, KAZAKHSTAN, LITHUANIA, LUXEMBOURG,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 36 days after the firm started it.

1. Firm started the recall: Mar 8, 202212. FDA classified it Class II: Apr 7, 202223. Published in FDA’s Enforcement Report: Apr 13, 202232022
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Other Abbott recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0891-2022 (March 8, 2022) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0891-2022 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA